Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Infectious Disease

Decoding the Lab: Your Diagnostic Results Explained

At a Glance

Diagnosing Hansen's disease (leprosy) involves a clinical exam, slit-skin smear, and skin biopsy. Key pathology findings include the presence of acid-fast bacilli (AFB) using a Fite-Faraco stain and perineural inflammation. Your report will also track bacterial levels to ensure treatment works.

Diagnosing Hansen’s disease is like putting together a puzzle. No single test is perfect, so doctors combine what they see on your skin with what they find under a microscope [1][2]. Understanding the terms in your lab results can help you confirm you are getting the right treatment for your specific type of infection.

The Diagnostic Process

The journey to a diagnosis usually involves three main steps:

  1. The Clinical Exam: Your doctor will check for the “cardinal signs,” such as patches of skin that have lost feeling or nerves that feel thick or tender to the touch [2][3].
  2. The Slit-Skin Smear (SSS): A provider take a tiny scrape of fluid from your earlobes or a skin lesion [2][4]. This fluid is stained and checked for acid-fast bacilli (AFB)—rod-shaped bacteria that hold onto a specific red dye even when washed with acid [4][5].
  3. The Skin Biopsy: A small piece of skin is removed and sent to a pathologist. This is often the most definitive way to confirm the disease, especially in early or “paucibacillary” (low-bacteria) cases [6][7].

Reading Your Pathology Report: Key Terms

When you look at your pathology report, you may see several technical terms. Here is what they mean for your care:

  • Fite-Faraco Stain (or Fite Stain): This is a specialized stain used specifically to find Mycobacterium leprae [8]. Standard stains used for other infections (like tuberculosis) often miss the delicate bacteria that cause Hansen’s disease, so seeing “Fite stain” on your report is a sign of a thorough exam [9][10].
  • Acid-Fast Bacilli (AFB): If your report says “AFB positive,” it means the bacteria were found [4]. If it says “AFB negative,” you may still have the disease; it just means the bacterial count was too low to see under a microscope, which is common in the “paucibacillary” form [11][12].
  • Granuloma: This is a cluster of immune cells. Seeing “granulomatous inflammation” means your body is actively trying to wall off the infection [7][13].
  • Perineural Involvement: This means the inflammation is located around your nerves, which is a classic hallmark of Hansen’s disease [14][15].

The Completeness Checklist

To ensure your diagnosis is accurate, check your lab or pathology report for the following:

  • [ ] Type of Stain: Does it mention Fite-Faraco?
  • [ ] Bacteriological Index (BI): This is a score from 0 to 6+ that measures the density of the bacteria. A higher number means more bacteria are present [16][17].
  • [ ] Morphological Index (MI): This measures the percentage of bacteria that look “solid” or alive [18]. This is used later to see if your treatment is working—the MI should drop to zero as the medicine kills the bacteria [18][19].
  • [ ] PCR Testing: If your biopsy was inconclusive, your doctor may order a PCR (Polymerase Chain Reaction) test. This looks for the DNA of the bacteria and is much more sensitive than a microscope alone [20][21].

If any of these items are missing, it is worth asking your doctor if they should be included or if a consultation with the National Hansen’s Disease Program is necessary for a second opinion [6][1].

What to Expect: A Monitoring Timeline

Once you begin treatment, your doctor will monitor you. Typically, if you are on a 12-month course, you will have routine clinical evaluations every few months to check for nerve function and drug side effects [22]. Follow-up slit-skin smears may be repeated yearly to ensure the Morphological Index (MI) is dropping to zero [18].

Common questions in this guide

What is a slit-skin smear for Hansen's disease?
A slit-skin smear involves taking a tiny scrape of fluid from the earlobes or a skin lesion. This fluid is examined under a microscope to look for the specific rod-shaped bacteria that cause the infection.
Why is the Fite-Faraco stain important on my pathology report?
The Fite-Faraco stain is a specialized dye used specifically to detect the delicate bacteria that cause Hansen's disease. Standard stains often miss these bacteria, so seeing this on your report ensures a thorough examination.
What does it mean if my pathology report is AFB negative?
An AFB negative result means no acid-fast bacilli were visible under the microscope. However, you may still have Hansen's disease if the bacterial count is very low, which is common in early or paucibacillary cases.
What is the difference between the Bacteriological Index (BI) and Morphological Index (MI)?
The Bacteriological Index measures the total density of bacteria in your sample. The Morphological Index measures the percentage of those bacteria that are actually alive, which helps doctors track if your treatment is successfully killing the infection.
What does perineural involvement mean on my biopsy results?
Perineural involvement indicates that inflammation is located around your nerves. This specific pattern of inflammation is a classic hallmark of Hansen's disease and strongly helps confirm the diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my pathology report confirm the presence of acid-fast bacilli (AFB)?
  2. 2.Was the Fite-Faraco stain used on my biopsy, or just a standard Ziehl-Neelsen stain?
  3. 3.What was my Bacteriological Index (BI) and Morphological Index (MI), and what do they tell us about my infection?
  4. 4.Did the biopsy show granulomas or inflammation around the nerves (perineural involvement)?
  5. 5.If my skin smear was negative, did we perform a PCR test to check for bacterial DNA?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    A study on the multidisciplinary diagnostic approach of leprosy: Can we prevent the recrudescence in the post-elimination Indian scenario?

    Mukherjee M, Ghatak D, Bhunia D, et al.

    Journal of family medicine and primary care 2023; (12(9)):2008-2013 doi:10.4103/jfmpc.jfmpc_2480_22.

    PMID: 38024916
  2. 2

    Clinico-Histological Correlation in Hansen's Disease: Three-year Experience at a Newly Established Tertiary Care Center in Central India.

    Semwal S, Joshi D, Goel G, et al.

    Indian journal of dermatology 2018; (63(6)):465-468 doi:10.4103/ijd.IJD_525_17.

    PMID: 30504973
  3. 3

    [Hansen disease, an emergent condition in Chile].

    San-Martín Á, Carrasco C, Fica A, et al.

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2018; (35(6)):722-728 doi:10.4067/S0716-10182018000600722.

    PMID: 31095196
  4. 4

    A Case of Saddle Nose Deformity Secondary to Lepromatous Leprosy.

    Pokala U, Poondru AR, Laxmi Santhi Swetha M S, et al.

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2025; (77(2)):1014-1018 doi:10.1007/s12070-024-05238-x.

    PMID: 40065940
  5. 5

    Hypopigmented mycosis fungoides mimicking leprosy successfully treated with oral and topical corticosteroids: a new great imitator?

    Djawad K

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2021; (30(2)):83-85.

    PMID: 34169706
  6. 6

    Are we witnessing a paradigm shift in leprosy: Two atypical presentations of histoid hansen's disease.

    Pathania V, Singh J, Sinha A, et al.

    International journal of mycobacteriology 2020; (9(1)):103-106 doi:10.4103/ijmy.ijmy_187_19.

    PMID: 32474499
  7. 7

    [Hansen's disease. Case report of tuberculoid leprosy in Chile].

    Armijo D, Aguirre F, Raimann MV, et al.

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2022; (39(1)):80-85 doi:10.4067/S0716-10182022000100080.

    PMID: 35735284
  8. 8

    Efficacy of fluorescent microscopy versus modified Fite-Faraco stain in skin biopsy specimens of leprosy cases - a comparative study.

    Kalagarla S, Alluri R, Saka S, et al.

    International journal of dermatology 2022; (61(5)):595-599 doi:10.1111/ijd.16046.

    PMID: 35061916
  9. 9

    Concomitant Tuberculous and Lepromatous Lymphadenitis: Clues and Pitfalls of Leprosy Concealed by Tuberculosis in Lymph Nodes.

    Farhan R, AbdullGaffar B, Al-Dabal L

    International journal of surgical pathology 2024; (32(8)):1470-1476 doi:10.1177/10668969241234327.

    PMID: 38494952
  10. 10

    Borderline Tuberculoid Leprosy Masquerading as Granuloma Annulare: A Clinical and Histological Pitfall.

    Zhu TH, Kamangar F, Silverstein M, Fung MA

    The American Journal of dermatopathology 2017; (39(4)):296-299 doi:10.1097/DAD.0000000000000698.

    PMID: 28328616
  11. 11

    Dominant marker (inter-simple sequence repeat-polymerase chain reaction) versus codominant marker (RLEP-polymerase chain reaction) for laboratory diagnosis of leprosy: A comparative evaluation.

    Mohanty PS, Bansal AK, Naaz F, et al.

    International journal of mycobacteriology 2020; (9(1)):18-23 doi:10.4103/ijmy.ijmy_190_19.

    PMID: 32474483
  12. 12

    Evaluation of Polymerase Chain Reaction (PCR) with Slit Skin Smear Examination (SSS) to Confirm Clinical Diagnosis of Leprosy in Eastern Nepal.

    Siwakoti S, Rai K, Bhattarai NR, et al.

    PLoS neglected tropical diseases 2016; (10(12)):e0005220 doi:10.1371/journal.pntd.0005220.

    PMID: 28027305
  13. 13

    Pathogenesis of Leprosy: An Insight Into B Lymphocytes and Plasma Cells.

    Fabel A, Giovanna Brunasso AM, Schettini AP, et al.

    The American Journal of dermatopathology 2019; (41(6)):422-427 doi:10.1097/DAD.0000000000001310.

    PMID: 30422829
  14. 14

    A Rare Combination of Pure Neuritic Leprosy with Morphea Leading to Diagnostic Confusion.

    Prakash B, Anoosha P, Singh S

    Indian journal of leprosy 2015; (87(2)):85-9.

    PMID: 27506006
  15. 15

    A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy.

    Madigan CA, Cambier CJ, Kelly-Scumpia KM, et al.

    Cell 2017; (170(5)):973-985.e10 doi:10.1016/j.cell.2017.07.030.

    PMID: 28841420
  16. 16

    Comparative evaluation of PCR amplification of RLEP, 16S rRNA, rpoT and Sod A gene targets for detection of M. leprae DNA from clinical and environmental samples.

    Turankar RP, Pandey S, Lavania M, et al.

    International journal of mycobacteriology 2015; (4(1)):54-9.

    PMID: 26655199
  17. 17

    Fluorescent Microscopy: A Useful and Adjunct Tool in Leprosy Diagnosis: A Cross Sectional Study.

    Soni S, Walke V, Asati D, et al.

    Iranian journal of pathology 2025; (20(1)):33-41 doi:10.30699/ijp.2024.2023590.3263.

    PMID: 40060232
  18. 18

    Optimizing treatment of lepromatous form of leprosy using ofloxacin on top of standard multi-drug therapy in National Referral Hospital, Jakarta, Indonesia.

    Priyanto MH, Yunifananda MS, Menaldi SLS, et al.

    F1000Research 2025; (14()):252 doi:10.12688/f1000research.161758.4.

    PMID: 41142960
  19. 19

    Alternate Anti-Leprosy Regimen for Multidrug Therapy Refractory Leprosy: A Retrospective Study from a Tertiary Care Center in North India.

    Narang T, Bishnoi A, Dogra S, et al.

    The American journal of tropical medicine and hygiene 2019; (100(1)):24-30 doi:10.4269/ajtmh.18-0256.

    PMID: 30298809
  20. 20

    qPCR detection of Mycobacterium leprae DNA in urine samples of leprosy patients using the Rlep gene target.

    Diana D, Harish MC

    Frontiers in molecular biosciences 2024; (11()):1435679 doi:10.3389/fmolb.2024.1435679.

    PMID: 39193223
  21. 21

    Neural leprosy investigation using electroneuromyography and the ML Flow rapid test: a case report.

    Oliveira Neto RR, Dorilêo GB, Mendonça ACDSF, Damazo AS

    Revista da Sociedade Brasileira de Medicina Tropical 2024; (57()):e008022024 doi:10.1590/0037-8682-0586-2023.

    PMID: 38359312
  22. 22

    Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States.

    Franco-Paredes C, Garcia-Creighton E, Henao-Martínez A, et al.

    Therapeutic advances in infectious disease 2022; (9()):20499361221135885 doi:10.1177/20499361221135885.

    PMID: 36387060

This page explains Hansen's disease diagnostic terminology for educational purposes only. Always consult your infectious disease specialist or dermatologist to interpret your specific lab results and biopsy reports.

Get notified when new evidence is published on Leprosy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.